FDA approves Medtronic’s larger aortic valve replacement system

The U.S. Food and Drug Administration recently approved Dublin-based Medtronic’s CoreValve Evolut R 34 mm valve.

Advertisement

This transcatheter aortic valve replacement system is intended to treat severe aortic stenosis in patients at a high or extreme risk for surgery who have an aortic valve diameter of 26 to 30 millimeter.

This new system offers a treatment solution for patients who were previously unable to undergo a transcatheter aortic valve replacement due to the larger size of their aortic valve, according to the report.

More articles on supply chain:

Apple electronic manufacturer to offer supply chain management services
Uber’s self-driving truck delivers first load: 50k cans of Budweiser
Steward Health Care taps HealthTrust for GPO

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.